Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.12 +0.01 (+0.90%)
At close: Nov 11, 2026 · 4:00 PM EST

Alx Oncology Holdings (ALXO) Net Long-Term Debt Issued (Repaid) (2021 - 2026)

Updated

Alx Oncology Holdings' Non-Current Debt was $9.71 million in Q2 2026, up 38.7% from $7 million a year earlier and up 194.5% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Net Long-Term Debt Issued (Repaid) (2021 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Debt at Alx Oncology Holdings came in at $4.53 million, down 52.1% from FY2024.

  • Non-Current Debt shows a three-year compound annual growth rate of -21.6% (FY2022 to FY2025).
  • In earlier years, Non-Current Debt was $9.47 million in FY2024 (-1.8%), $9.64 million in FY2023 (+2.7%) and $9.39 million in FY2022.
  • The Q2 2026 figure marks the highest quarterly Non-Current Debt since Q3 2024.
  • Compared with a year earlier, Non-Current Debt was higher in two of the last eight quarters, with an average decline of 19.7%.
  • The best year-over-year quarter for Non-Current Debt over five years was Q2 2026 (growth of 38.7%); the worst was Q1 2026 (a decline of 60.0%).
  • Per Business Quant data, ALXO's Non-Current Debt in the three quarters before Q2 2026 was $3.3 million (Q1 2026), $4.53 million (Q4 2025) and $5.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Alx Oncology Holdings 153.42 Mn -230.55 Mn - -1.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.54 Mn
Mar 31, 2026 -1.61 Mn
Dec 31, 2025 -660,000.00
Sep 30, 2025 -160,000.00
Jun 30, 2025 -237,000.00
Mar 31, 2025 -307,000.00
Dec 31, 2024 -76,000.00
Sep 30, 2024 -358,000.00
Jun 30, 2024 -218,000.00
Mar 31, 2024 -175,000.00
Dec 31, 2023 -63,000.00
Sep 30, 2023 -111,000.00
Jun 30, 2023 -107,000.00
Mar 31, 2023 -107,000.00
Dec 31, 2022 -107,000.00
Sep 30, 2022 -141,000.00
Jun 30, 2022 -35,000.00
Mar 31, 2022 -105,000.00
Dec 31, 2021 -104,000.00
Sep 30, 2021 -104,000.00
API Access

Alx Oncology Holdings Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ALXO&period=max&api_key=YOUR_API_KEY